CARsgen Therapeutics Holdings Ltd
HKEX:2171

Watchlist Manager
CARsgen Therapeutics Holdings Ltd Logo
CARsgen Therapeutics Holdings Ltd
HKEX:2171
Watchlist
Price: 8.52 HKD 1.19% Market Closed
Market Cap: 4.9B HKD
Have any thoughts about
CARsgen Therapeutics Holdings Ltd?
Write Note

CARsgen Therapeutics Holdings Ltd
Cash Taxes Paid

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CARsgen Therapeutics Holdings Ltd
Cash Taxes Paid Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Taxes Paid CAGR 3Y CAGR 5Y CAGR 10Y
CARsgen Therapeutics Holdings Ltd
HKEX:2171
Cash Taxes Paid
ÂĄ1.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Cash Taxes Paid
-ÂĄ579.2m
CAGR 3-Years
-38%
CAGR 5-Years
-50%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Cash Taxes Paid
-ÂĄ145.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Cash Taxes Paid
-ÂĄ537.3m
CAGR 3-Years
-55%
CAGR 5-Years
-44%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Cash Taxes Paid
-ÂĄ2.7B
CAGR 3-Years
-13%
CAGR 5-Years
-33%
CAGR 10-Years
-44%
Imeik Technology Development Co Ltd
SZSE:300896
Cash Taxes Paid
-ÂĄ416.7m
CAGR 3-Years
-69%
CAGR 5-Years
-40%
CAGR 10-Years
N/A
No Stocks Found

CARsgen Therapeutics Holdings Ltd
Glance View

Market Cap
4.9B HKD
Industry
Biotechnology

CARsgen Therapeutics Holdings Ltd. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of CAR-T cell therapies. The company is headquartered in Shanghai, Shanghai and currently employs 573 full-time employees. The company went IPO on 2021-06-18. The Company’s therapies are applied in the treatment of hematological malignancies and solid tumors. The firm have developed an upgraded B cell maturation antigen (BCMA) targeted CAR-T product, CT053, which is its sole core product candidate. The firm conducts its businesses in China and the United States.

Intrinsic Value
12.81 HKD
Undervaluation 33%
Intrinsic Value
Price

See Also

What is CARsgen Therapeutics Holdings Ltd's Cash Taxes Paid?
Cash Taxes Paid
1.7m CNY

Based on the financial report for Dec 31, 2023, CARsgen Therapeutics Holdings Ltd's Cash Taxes Paid amounts to 1.7m CNY.

What is CARsgen Therapeutics Holdings Ltd's Cash Taxes Paid growth rate?
Cash Taxes Paid CAGR 1Y
-77%

Over the last year, the Cash Taxes Paid growth was -77%.

Back to Top